Cytokinetics EBITDA 2010-2024 | CYTK

Cytokinetics EBITDA for the quarter ending December 31, 2024 was $-0.137B, a 12.86% increase year-over-year.

  • Cytokinetics 2024 EBITDA was -0.527B, a 8.76% increase from 2023.
  • Cytokinetics 2023 EBITDA was -0.484B, a 52.11% increase from 2022.
  • Cytokinetics 2022 EBITDA was -0.318B, a 73% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Cytokinetics EBITDA 2010-2024 | CYTK

  • Cytokinetics 2024 EBITDA was -0.527B, a 8.76% increase from 2023.
  • Cytokinetics 2023 EBITDA was -0.484B, a 52.11% increase from 2022.
  • Cytokinetics 2022 EBITDA was -0.318B, a 73% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.